Single User License
INR 161350
Site License
INR 322700
Corporate User License
INR 484050

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2621CTIDB
  • |
  • Pages: 95
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015" provides data on the Pharyngeal Neoplasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pharyngeal Neoplasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pharyngeal Neoplasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Pharyngeal Neoplasm 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Pharyngeal Neoplasm 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Pharyngeal Neoplasm Therapeutics Clinical Trials 33

Prominent Drugs 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Sanofi 36

Clinical Trial Overview of Sanofi 36

F. Hoffmann-La Roche Ltd. 37

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37

E. Merck KG 38

Clinical Trial Overview of E. Merck KG 38

C. H. Boehringer Sohn AG & Co. KG 39

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 39

GlaxoSmithKline plc 40

Clinical Trial Overview of GlaxoSmithKline plc 40

Merck & Co., Inc. 41

Clinical Trial Overview of Merck & Co., Inc. 41

Oncolytics Biotech Inc. 42

Clinical Trial Overview of Oncolytics Biotech Inc. 42

Celgene Corporation 43

Clinical Trial Overview of Celgene Corporation 43

Bristol-Myers Squibb Company 44

Clinical Trial Overview of Bristol-Myers Squibb Company 44

Clinical Trial Overview of Top Institutes / Government 45

National Cancer Institute 45

Clinical Trial Overview of National Cancer Institute 45

Sun Yat-sen University 50

Clinical Trial Overview of Sun Yat-sen University 50

Baylor College of Medicine 52

Clinical Trial Overview of Baylor College of Medicine 52

Radiation Therapy Oncology Group 53

Clinical Trial Overview of Radiation Therapy Oncology Group 53

Sun Yat-Sen University Cancer Center 54

Clinical Trial Overview of Sun Yat-Sen University Cancer Center 54

Chinese University of Hong Kong 55

Clinical Trial Overview of Chinese University of Hong Kong 55

FUDAN University 56

Clinical Trial Overview of FUDAN University 56

Memorial Sloan Kettering Cancer Center 57

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 57

European Organization for Research and Treatment of Cancer 58

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 58

Five Key Clinical Profiles 59

Appendix 93

Abbreviations 93

Definitions 93

Research Methodology 94

Secondary Research 94

About GlobalData 95

Contact Us 95

Disclaimer 95

Source 95

List of Figures

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Pharyngeal Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Pharyngeal Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Pharyngeal Neoplasm Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Pharyngeal Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Pharyngeal Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Pharyngeal Neoplasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35

GlobalData Methodology 94

List of Tables

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Region, 2015* 7

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Pharyngeal Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Pharyngeal Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Pharyngeal Neoplasm Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Pharyngeal Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Pharyngeal Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Pharyngeal Neoplasm Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Pharyngeal Neoplasm Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Pharyngeal Neoplasm Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Pharyngeal Neoplasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34

Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 36

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 38

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 39

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 40

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 41

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2015* 42

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 43

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 44

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 45

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 50

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 52

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 53

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-Sen University Cancer Center, 2015* 54

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 55

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 56

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 57

Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pharyngeal Neoplasm Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Pharyngeal Neoplasm, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com